NCT06270030: Safety, Tolerability and Pharmacokinetics of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Chinese With Presbyopia
- State
- Completed
- Phase
- Phase 1
- People
- 21 taking part
- Started
- 4 Mar 2024
- Primary completion
- 10 Apr 2024
- Arms
- LNZ101 (Aceclidine /Brimonidine) ophthalmic solution
- Results
- None posted
- 21 Feb 2024: Trial registered
- 4 Mar 2024: Trial started
- 10 Apr 2024: Trial completed